EBV LMP2 419-427 Peptide (HLA-A*24:02) - TYGPVFMCL

The EBV LMP2 419-427 peptide (TYGPVFMCL) is a well-defined MHC class I epitope used to stimulate and measure antigen-specific CD8+ T-cell responses in immune monitoring workflows-especially when working with HLA-A*24:02 (HLA-A24). This single peptide format is ideal for targeted readouts (e.g., epitope-specific reactivity), while still pairing well with broader screening approaches such as peptide pools.

The Epstein-Barr Virus (EBV) Latent membrane protein 2 (LMP2) Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Latent membrane protein 2 (LMP2) Peptide, H-TYGPVFMCL-OH (Uniprot: P13285 aa: 419-427) from JPT is produced under strict quality control and quality management.

EBV LMP2 419-427 Peptide (HLA-A*24:02) - TYGPVFMCL - Specifications

• Peptide sequence: H-TYGPVFMCL-OH
• Amount: 1 mg
• Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
• Delivery Format: Freeze-dried in plastic vial
• Application(s): T-cell immunity
• Condition(s)/Topic(s): Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma, Infectious mononucleosis
• Standard Delivery Time: approx. 10 days

Visit our webpage for more information on Peptide Tools to Study EBV. We also offer a broad range of Antigen Peptides, with more than 1000 items!

Common use cases of EBV LMP-2 419-427

• Epitope-specific stimulation in ELISPOT / ICS
• Functional readouts in cytotoxicity and proliferation assays
• Immune monitoring in EBV-related research contexts (infection and oncology)

Key benefits

• HLA-A*24:02-restricted epitope: supports precise, allele-matched T-cell stimulation workflows
• Sequence-defined (TYGPVFMCL): helps standardize assay conditions across experiments
• Works as a standalone epitope reagent or alongside PepMix™ peptide pools and MHC multimer strategies for immune monitoring (where applicable)

Need help choosing the right format?

If you’re deciding between a single epitope peptide vs. an overlapping pool:

• Choose single epitope peptide (this product) when you want allele-restricted, epitope-specific stimulation/readouts (e.g., validating a known response, comparing donors, titrating concentration).
• Choose an overlapping LMP2 pool when you want broader coverage of LMP2 to map responses or avoid missing responses due to unknown epitopes.

Talk to a scientist: If you tell us your assay type (ELISPOT/ICS/killing), donor HLA, and readout, we can help you select the best peptide format and controls.